Mal-PEG2-C2-Boc
CAS No. 1374666-31-5
Mal-PEG2-C2-Boc ( Mal-PEG2-T-Butyl Ester )
Catalog No. M26980 CAS No. 1374666-31-5
Mal-PEG2-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
25MG | 50 | Get Quote |
|
50MG | 68 | Get Quote |
|
100MG | 88 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMal-PEG2-C2-Boc
-
NoteResearch use only, not for human use.
-
Brief DescriptionMal-PEG2-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionMal-PEG2-C2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
SynonymsMal-PEG2-T-Butyl Ester
-
PathwayOthers
-
TargetOther Targets
-
RecptorFungal
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1374666-31-5
-
Formula Weight313.4
-
Molecular FormulaC15H23NO6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)OC(=O)CCOCCOCCN1C(=O)C=CC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
NNMTi
NNMTi? is a substrate site-targeting, selective nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 1.2 μM;?50 μM SAM, 100 μM NCA) that reduces 3T3-L1 lipogenesis (EC50 = 30μM) and adipocytes 1-methylnicotinamide level (EC50 = 2.3 μM) without affecting related methyltransferases & enzymes in the NAD+ salvage pathwayNNMTi treatment will rescue age-related deficits in muSC activity to promote superior regeneration post-injury in aging muscle.
-
Schinifoline
Schinifoline is a quinolone derivative extracted from Zanthoxylum schinifolium Sieb with cytotoxic activity that promotes radiosensitization of cancer cells, affects the cell cycle and apoptosis.
-
DS-2330
DS-2330 is a phosphorous lowering agent for treating hyperphosphatemia in chronic kidney disease.